Data / Form D filings / HYDROCISION INC
HYDROCISION INC: Form D filings
HYDROCISION INC, a biotechnology company in North Billerica, MA, filed 4 Form D notices with the SEC between 2009 and 2025. The latest, on April 1, 2025, reports $2.5 million sold of a $3.9 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 267 BOSTON ROAD, SUITE 28, North Billerica, MA, 01862
- Phone
- (978) 474-9300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1031309
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | New notice | $3,850,000 | $2,530,912 | $1,319,088 | 12 | Nov 15, 2024 | sec.gov |
| Mar 24, 2017 | New notice | $4,000,000 | $3,000,000 | $1,000,000 | 10 | Mar 9, 2017 | sec.gov |
| Apr 14, 2010 | New notice | $700,000 | $623,635 | $76,365 | 8 | Mar 30, 2010 | sec.gov |
| Sep 11, 2009 | Amendment | $4,500,000 | $3,024,300 | $1,475,700 | 11 | Nov 18, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| PAUL E. KOWALSKI | Executive Officer | |
| DOUG E. WALL | Director | |
| TERRY E. WALL | Director | |
| LONG E. ZHAN | Director | |
| BRYAN E. GRULKE | Director | |
| HOWARD W. DONNELLY | Director | |
| RICHARD A. LYTLE, III | Executive Officer, Director | |
| THOMAS D. ABERT | Executive Officer | |
| MARC E. GOLDBERG | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Mar 31, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what HYDROCISION INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.